Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Eikon Therapeutics logo

Eikon Therapeutics

Recent Finacing

Series D

Recent Raise

$350.7M

Eikon Therapeutics operates a live-cell super-resolution microscopy and single-molecule tracking platform using automation, ML, and HPC to run high-throughput protein-dynamics drug screens and advance oncology, immunology, and neurologic programs.

Founded 2019
California, United States
251-500
Private
eikontx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Life Science
Medical

Recent Investors

Lux Capital logo
The Column Group logo
Foresite Capital logo
General Catalyst logo
Innovation Endeavors logo
E15 VC logo
Soros Capital logo
U
AME Cloud Ventures logo
StepStone Group logo
T. Rowe Price Associates logo
Harel Insurance Investments & Financial Services logo

Financials

$1.1B

Total Raised

4

Funding rounds

19

Investors


Team

Upgrade to view the team

See the team members at Eikon Therapeutics.